Dosage forms of risedronate

Details Dosage forms of risedronate Dosage forms of risedronate

1997-03-12

1999-08-10

Levy, Neil S.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

424490, 424463, 424482, 424486, A61K 914

Patent

active

059356022

ABSTRACT:
The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical compostion which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms prohibit the exposure of the risedronate active ingredient to the epichelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach and thereby protects said tissues from erosion, ulceration or other like irritation. Accordingly, the said dosage forms effect the delivery to the lower intestinal tract of said human or other mammal of a safe and effective amount of the risedronate active ingredient, and substantially alleviate the esophagitis or esophageal irritation which sometimes accompanies the oral administration of risedronate active ingredients.

REFERENCES:
patent: 5047246 (1991-09-01), Gallian et al.
patent: 5158944 (1992-10-01), Makino et al.
patent: 5358941 (1994-10-01), Bechard et al.
patent: 5616571 (1997-04-01), Daifotis et al.
patent: 5622721 (1997-04-01), Dansereau et al.
patent: 5681590 (1997-10-01), Bechard et al.
patent: 5767124 (1998-06-01), Draper et al.

Affiliated with

Also associated with

Rating

Dosage forms of risedronate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage forms of risedronate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms of risedronate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1117723